Antibiotics

Jason Pogue, PharmD, BCPS-ID, explains his team’s study regarding the susceptibility of Pseudomonas isolates to ceftolozane/tazobactam.

Milena McLaughlin, PharmD, MSc, explains the best way to determine an alternative agent during a drug shortage.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how restrictions on commercial automated susceptibility testing can affect patient care.

A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.

Arjun Srinivasan, MD, shares how to focus your efforts for infectious disease outbreak investigations.

New research suggests that a vaccine designed to protect against meningitis may also protect against gonorrhea infections.

Meghan Jeffres, PharmD, explains the importance of discussing cross-reactivity among beta-lactams.

For the most challenging of microbial threats, one microbiologist is trying an old tactic in a new era.

Cases of antibiotic-resistant gonorrhea are on the rise, and the bacteria may soon become untreatable if new antibiotics and diagnostic tools are not developed.

Milena McLaughlin, PharmD, MSc, explains different strategies institutions can take to obtain antimicrobials that are on shortage.

Penn researchers find that cases of recurrent C. difficile infections are rapidly increasing, underscoring the need for new treatment options, such as fecal microbiota transplants.

Jason Pogue, PharmD, BCPS-ID, explains the limitations of the current drugs for the treatment of Pseudomonas aeruginosa infections.

In a new study conducted in a healthcare system in the Bronx, a team of healthcare providers has created a new program to cut hospital readmission rates in patients receiving outpatient IV antibiotic treatment.

Caetano Sabino, BSc, explains how photodynamic therapy can be used to challenge microbial resistance of localized infections.

Conan MacDougall, PharmD, explains what individuals should consider when it comes to adopting interventions in antibiotic stewardship programs.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how the role of antimicrobial susceptibility tests can be undermined by delays between approval of new antibiotics and the tests that will optimize their use.

More than 200 scientists, medical professionals, and environmental researchers have released a statement calling on the international community to take further steps to limit the use of triclosan, triclocarban, and other antimicrobial compounds.

Milena McLaughlin, PharmD, MSc, explains the key points that should be incorporated into institutional plans for dealing with antimicrobial shortages.

Snigdha Vallabhaneni, MD, MPH, discusses the drugs available to treat Candida infections.

Conan MacDougall, PharmD, explains how practitioners can adopt antibiotic stewardship interventions that will be beneficial to their specific practice settings.

As new antibiotics are not being developed fast enough to fight against drug-resistant bacteria, new research shows that probiotic bacteria found in cheese and yogurt may offer an effective alternative.

Elizabeth Phillips, MD, FRCPC, FRACP, explains different strategies for improving antibiotic allergy management.

Meghan Jeffres, PharmD, explains what practitioners should keep in mind when prescribing beta-lactams.

Conan MacDougall, PharmD, discusses some interventions that have been shown to produce negative behavioral changes for antibiotic stewardship.

Pleuromutilin antibiotics, meningococcal disease, tuberculosis, a new fluoroquinolone to treat acute bacterial skin and skin structure infections, and WHO’s position on HPV vaccine recommendations makes up this week’s Top 5 articles.

Belinda Ostrowsky, MD, MPH, explains how to treat patients who expect to receive an antibiotic, but should not.

Kirk Hevener, PharmD, PhD, explains why narrow-spectrum antibiotics are more beneficial for treating C. difficile.

A new Johns Hopkins study finds that one fifth of hospitalized adults experience adverse effects from prescribed antibiotics; one fifth of those effects occurred in patients who should not have been prescribed antibiotics in the first place.

Milena McLaughlin, PharmD, MSc, explains strategies institutions can take to address antimicrobial shortages.

Although treatment for chronic Lyme has provided some patients with relief of their symptoms, it may also expose them to complications related to the prescribed modalities.